Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Agenus Current Ratio 2006-2018 | AGEN

Agenus current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Agenus Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.07B $0.06B 1.16
2018-06-30 $0.07B $0.05B 1.32
2018-03-31 $0.07B $0.03B 2.16
2017-12-31 $0.07B $0.06B 1.30
2017-09-30 $0.08B $0.05B 1.55
2017-06-30 $0.11B $0.03B 3.36
2017-03-31 $0.14B $0.04B 3.80
2016-12-31 $0.09B $0.04B 2.24
2016-09-30 $0.11B $0.04B 3.14
2016-06-30 $0.14B $0.03B 4.12
2016-03-31 $0.16B $0.03B 5.17
2015-12-31 $0.18B $0.03B 6.36
2015-09-30 $0.21B $0.03B 7.39
2015-06-30 $0.15B $0.03B 5.78
2015-03-31 $0.09B $0.02B 4.06
2014-12-31 $0.04B $0.01B 4.62
2014-09-30 $0.06B $0.02B 3.54
2014-06-30 $0.07B $0.02B 3.61
2014-03-31 $0.08B $0.01B 5.24
2013-12-31 $0.03B $0.01B 2.74
2013-09-30 $0.03B $0.01B 3.20
2013-06-30 $0.01B $0.01B 2.01
2013-03-31 $0.02B $0.01B 3.18
2012-12-31 $0.02B $0.01B 4.70
2012-09-30 $0.03B $0.01B 5.34
2012-06-30 $0.03B $0.01B 5.77
2012-03-31 $0.03B $0.01B 4.71
2011-12-31 $0.01B $0.01B 2.53
2011-09-30 $0.02B $0.01B 2.73
2011-06-30 $0.01B $0.01B 2.77
2011-03-31 $0.02B $0.01B 3.03
2010-12-31 $0.02B $0.01B 3.85
2010-09-30 $0.03B $0.04B 0.64
2010-06-30 $0.03B $0.01B 6.25
2010-03-31 $0.03B $0.01B 4.57
2009-12-31 $0.03B $0.01B 5.89
2009-09-30 $0.04B $0.01B 5.81
2009-06-30 $0.02B $0.01B 3.51
2009-03-31 $0.03B $0.01B 4.36
2008-12-31 $0.04B $0.01B 5.07
2008-09-30 $0.04B $0.01B 4.66
2008-06-30 $0.05B $0.01B 5.97
2008-03-31 $0.04B $0.01B 4.77
2007-12-31 $0.02B $0.01B 2.48
2007-09-30 $0.03B $0.01B 3.24
2007-06-30 $0.03B $0.01B 3.75
2007-03-31 $0.04B $0.01B 5.03
2006-12-31 $0.04B $0.01B 4.66
2006-09-30 $0.03B $0.01B 2.51
2006-06-30 $0.04B $0.01B 2.68
2006-03-31 $0.05B $0.02B 3.29
2005-12-31 $0.07B $0.02B 3.50
2005-09-30 $0.08B $0.02B 4.52
2005-06-30 $0.10B $0.02B 4.92
2005-03-31 $0.12B $0.02B 6.83
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.359B $0.043B
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Biogen (BIIB) United States $65.929B 12.77
Celgene (CELG) United States $63.373B 11.74
Vertex Pharmaceuticals (VRTX) United States $48.023B 64.33
Regeneron Pharmaceuticals (REGN) United States $46.170B 21.45
Illumina (ILMN) United States $44.429B 52.84
Alexion Pharmaceuticals (ALXN) United States $29.015B 17.98
Incyte (INCY) United States $17.925B 167.48
BioMarin Pharmaceutical (BMRN) United States $16.143B 0.00
Seattle Genetics (SGEN) United States $11.201B 0.00
Exact Sciences (EXAS) United States $10.278B 0.00
Sarepta Therapeutics (SRPT) United States $9.393B 0.00
QIAGEN (QGEN) Netherlands $8.890B 29.07
Alnylam Pharmaceuticals (ALNY) United States $8.262B 0.00
BeiGene (BGNE) Cayman Islands $8.259B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bio-Techne Corp (TECH) United States $7.316B 49.29
Bluebird Bio (BLUE) United States $7.298B 0.00
Moderna (MRNA) United States $6.553B 0.00
Exelixis (EXEL) United States $6.350B 14.85
Amarin (AMRN) Ireland $5.554B 0.00
Alkermes (ALKS) Ireland $5.204B 0.00
Galapagos (GLPG) Belgium $5.177B 0.00
Array BioPharma (ARRY) United States $5.056B 0.00
Guardant Health (GH) United States $4.324B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.034B 0.00
Allogene Therapeutics (ALLO) United States $3.728B 0.00
Horizon Pharma Public (HZNP) Ireland $3.611B 14.85
Blueprint Medicines (BPMC) United States $3.388B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.346B 0.00
Emergent Biosolutions (EBS) United States $3.319B 27.96
Ultragenyx Pharmaceutical (RARE) United States $3.062B 0.00
Genomic Health (GHDX) United States $3.022B 78.93
Ascendis Pharma (ASND) Denmark $2.941B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.937B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.854B 0.00
Immunomedics (IMMU) United States $2.735B 0.00
China Biologic Products (CBPO) China $2.677B 19.06
Global Blood Therapeutics (GBT) United States $2.640B 0.00
Reata Pharmaceuticals (RETA) United States $2.596B 0.00
Repligen (RGEN) United States $2.588B 80.82
Mirati Therapeutics (MRTX) United States $2.585B 0.00
Ligand Pharmaceuticals (LGND) United States $2.527B 18.15
Arena Pharmaceuticals (ARNA) United States $2.464B 0.00
Halozyme Therapeutics (HALO) United States $2.439B 54.42
Myriad Genetics (MYGN) United States $2.343B 23.87
Akcea Therapeutics (AKCA) United States $2.343B 0.00
Amicus Therapeutics (FOLD) United States $2.099B 0.00
Insmed (INSM) United States $2.006B 0.00
Denali Therapeutics (DNLI) United States $1.999B 0.00
Acceleron Pharma (XLRN) United States $1.940B 0.00
Spark Therapeutics (ONCE) United States $1.921B 0.00
Atara Biotherapeutics (ATRA) United States $1.798B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.782B 0.00
Medicines (MDCO) United States $1.765B 0.00
MyoKardia (MYOK) United States $1.757B 0.00
AnaptysBio (ANAB) United States $1.740B 0.00
NeoGenomics (NEO) United States $1.724B 141.92
CRISPR Therapeutics AG (CRSP) Switzerland $1.660B 0.00
REGENXBIO (RGNX) United States $1.657B 22.23
Zai Lab Unsponsored ADR (ZLAB) China $1.637B 0.00
Allakos (ALLK) United States $1.530B 0.00
Innoviva (INVA) United States $1.482B 4.09
Myovant Sciences (MYOV) United Kingdom $1.479B 0.00
UniQure (QURE) Netherlands $1.467B 0.00
ALECTOR INC (ALEC) United States $1.430B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.388B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Aimmune Therapeutics (AIMT) United States $1.363B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.342B 0.00
Cambrex (CBM) United States $1.286B 13.87
Clovis Oncology (CLVS) United States $1.278B 0.00
GOSSAMER BIO (GOSS) United States $1.273B 0.00
Lion Biotechnologies (IOVA) United States $1.218B 0.00
Codexis (CDXS) United States $1.178B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.115B 0.00
Audentes Therapeutics (BOLD) United States $1.110B 0.00
WAVE Life Sciences (WVE) Singapore $1.093B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.076B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.072B 43.32
Rubius Therapeutics (RUBY) United States $1.067B 0.00
Puma Biotechnology (PBYI) United States $1.020B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.011B 0.00
Coherus BioSciences (CHRS) United States $0.986B 0.00
Editas Medicine (EDIT) United States $0.983B 0.00
Epizyme (EPZM) United States $0.967B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.959B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Fate Therapeutics (FATE) United States $0.926B 0.00
Retrophin (RTRX) United States $0.864B 0.00
Sangamo Therapeutics (SGMO) United States $0.864B 0.00
Athenex (ATNX) United States $0.854B 0.00
Vericel (VCEL) United States $0.840B 0.00
CytomX Therapeutics (CTMX) United States $0.791B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.782B 0.00
Apellis Pharmaceuticals (APLS) United States $0.780B 0.00
InflaRx (IFRX) Germany $0.767B 0.00
Novavax (NVAX) United States $0.766B 0.00
G1 THERAPEUTICS (GTHX) United States $0.752B 0.00
Heska (HSKA) United States $0.751B 61.47
Intra-Cellular Therapies (ITCI) United States $0.733B 0.00
Principia Biopharma (PRNB) United States $0.724B 0.00
ANI Pharmaceuticals (ANIP) United States $0.721B 13.80
Cellectis (CLLS) France $0.715B 0.00
Arvinas (ARVN) United States $0.711B 0.00
Dynavax Technologies (DVAX) United States $0.689B 0.00
Revance Therapeutics (RVNC) United States $0.665B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.654B 0.00
Cara Therapeutics (CARA) United States $0.650B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.641B 0.00
Synthorx (THOR) United States $0.637B 0.00
Twist Bioscience (TWST) United States $0.630B 0.00
Viking Therapeutics (VKTX) United States $0.627B 0.00
Acorda Therapeutics (ACOR) United States $0.623B 8.09
Intellia Therapeutics (NTLA) United States $0.604B 0.00
RA PHARMCTL INC (RARX) United States $0.601B 0.00
UROGEN PHARMA (URGN) Israel $0.573B 0.00
Kura Oncology (KURA) United States $0.572B 0.00
Anika Therapeutics (ANIK) United States $0.569B 23.56
Eidos Therapeutics (EIDX) United States $0.567B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
Osiris Therapeutics (OSIR) United States $0.554B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.550B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Arcus Biosciences (RCUS) United States $0.516B 0.00
PDL BioPharma (PDLI) United States $0.511B 8.33
DBV Technologies (DBVT) France $0.493B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.492B 0.00
Zymeworks (ZYME) Canada $0.482B 0.00
UNITY Biotechnology (UBX) $0.477B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.476B 0.00
Senesco Technologies (ELOX) United States $0.458B 0.00
Scholar Rock Holding (SRRK) United States $0.455B 0.00
Zealand Pharma (ZEAL) Denmark $0.453B 5.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.445B 0.00
BeyondSpring (BYSI) United States $0.444B 0.00
ObsEva SA (OBSV) Switzerland $0.439B 0.00
Replimune (REPL) United States $0.437B 0.00
Five Prime Therapeutics (FPRX) United States $0.421B 0.00
Kezar Life Sciences (KZR) United States $0.403B 0.00
Cytokineticsorporated (CYTK) United States $0.402B 0.00
Mesoblast (MESO) Australia $0.401B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.398B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.387B 0.00
OSMOTICA PHARM (OSMT) United States $0.375B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.371B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
Kindred Biosciences (KIN) United States $0.364B 0.00
MediciNova (MNOV) United States $0.362B 0.00
AVROBIO (AVRO) United States $0.360B 0.00
Inovio Pharmaceuticals (INO) United States $0.358B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.340B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.327B 0.00
Urovant Sciences (UROV) United States $0.318B 0.00
Evelo Biosciences (EVLO) United States $0.315B 0.00
Abeona Therapeutics (ABEO) United States $0.314B 0.00
Albireo Pharma (ALBO) United States $0.310B 0.00
Solid Biosciences (SLDB) United States $0.309B 0.00
Cellular Biomedicine (CBMG) United States $0.308B 0.00
Aduro Biotech (ADRO) United States $0.307B 0.00
XBiotech (XBIT) United States $0.306B 0.00
Magenta Therapeutics (MGTA) United States $0.305B 0.00
Intec Pharma (NTEC) Israel $0.293B 0.00
Enochian BioSciences (ENOB) United States $0.291B 0.00
Constellation Pharmaceuticals (CNST) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.282B 0.00
Kala Pharmaceuticals (KALA) United States $0.280B 0.00
AC Immune SA (ACIU) Switzerland $0.277B 0.00
Geron (GERN) United States $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.273B 0.00
Sorrento Therapeutics (SRNE) United States $0.271B 0.00
Axsome Therapeutics (AXSM) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.258B 0.00
Merus (MRUS) Netherlands $0.254B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.252B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.251B 0.00
Synlogic (SYBX) United States $0.242B 0.00
Seres Therapeutics (MCRB) United States $0.241B 0.00
Celcuity (CELC) United States $0.240B 0.00
Kamada (KMDA) Israel $0.236B 10.64
MannKind (MNKD) United States $0.235B 0.00
Verastem (VSTM) United States $0.231B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Adverum Biotechnologies (ADVM) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.218B 0.00
ChromaDex (CDXC) United States $0.215B 0.00
Cerecor (CERC) United States $0.211B 0.00
Athersys (ATHX) United States $0.210B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
TOCAGEN INC (TOCA) United States $0.207B 0.00
Syros Pharmaceuticals (SYRS) United States $0.205B 0.00
Arbutus Biopharma (ABUS) Canada $0.202B 0.00
LogicBio Therapeutics (LOGC) United States $0.201B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.199B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
CorMedix Inc (CRMD) United States $0.196B 0.00
Spero Therapeutics (SPRO) United States $0.193B 0.00
Aptinyx (APTX) United States $0.187B 0.00
ADMA Biologics Inc (ADMA) United States $0.185B 0.00
Axovant Sciences (AXGT) United Kingdom $0.184B 0.00
Compugen (CGEN) Israel $0.181B 0.00
Protagonist Therapeutics (PTGX) United States $0.173B 0.00
Menlo Therapeutics (MNLO) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.163B 80.19
Mersana Therapeutics (MRSN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Proteostasis Therapeutics (PTI) United States $0.148B 0.00
BioTime (BTX) United States $0.146B 0.00
OvaScience (MLND) United States $0.142B 0.00
Allena Pharmaceuticals (ALNA) United States $0.133B 0.00
BioXcel Therapeutics (BTAI) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.129B 0.00
Cohbar (CWBR) United States $0.129B 0.00
Cue Biopharma (CUE) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.127B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Unum Therapeutics (UMRX) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
XOMA (XOMA) United States $0.119B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Trevena (TRVN) United States $0.117B 0.00
Checkpoint Therapeutics (CKPT) United States $0.114B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Mustang Bio (MBIO) United States $0.112B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.107B 0.00
Equillium (EQ) United States $0.105B 0.00
VolitionRX (VNRX) Singapore $0.103B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
Chiasma (CHMA) United States $0.097B 0.00
VTv Therapeutics (VTVT) United States $0.094B 0.00
NantKwest (NK) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Cel-Sci (CVM) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.081B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.078B 0.00
Alimera Sciences (ALIM) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
Provention Bio (PRVB) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
PHASEBIO PHARMA (PHAS) United States $0.073B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.067B 12.66
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Celldex Therapeutics (CLDX) United States $0.065B 0.00
SESEN BIO, INC (SESN) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Eyenovia (EYEN) United States $0.057B 0.00
ARAVIVE, INC (ARAV) United States $0.057B 4.98
Proteon Therapeutics (PRTO) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
VIVUS (VVUS) United States $0.056B 0.00
Clearside Biomedical (CLSD) United States $0.056B 0.00
Ophthotech (OPHT) United States $0.055B 0.00
Vaccinex (VCNX) United States $0.055B 0.00
Alcobra (ARCT) United States $0.053B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Entera Bio (ENTX) Israel $0.051B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
OVID THERAPEUTC (OVID) United States $0.046B 0.00
Selecta Biosciences (SELB) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
VistaGen Therapeutics (VTGN) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
Celsion (CLSN) United States $0.040B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
Curis (CRIS) United States $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Arsanis (ASNS) United States $0.037B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
AZURRX BIOPHARM (AZRX) United States $0.034B 0.00
Leap Therapeutics (LPTX) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.031B 5.08
Galena Biopharma (SLS) United States $0.031B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Motif Bio Plc (MTFB) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Oragenics (OGEN) United States $0.026B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.024B 0.00
Vical (VICL) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
GTx (GTXI) United States $0.021B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
IBio (IBIO) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.63
ATyr Pharma (LIFE) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00